Neogen 

$9.49
37
+$0.08+0.85% Today

Statistics

Day High
9.53
Day Low
9.3
52W High
11.43
52W Low
3.87
Volume
445,447
Avg. Volume
3,363,675
Mkt Cap
2.06B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

9AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-2.82
-1.85
-0.87
0.1
Expected EPS
0.058125
Actual EPS
N/A

Financials

-122.06%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
1.79BRevenue
-2.18BNet Income

Analyst Ratings

$9.50Average Price Target
The highest estimate is 12.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
33%
Hold
67%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NEOG. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Idexx Laboratories
IDXX
Mkt Cap45.35B
IDEXX Laboratories, Inc. specializes in diagnostics and software for animal health, directly competing with Neogen's animal safety products.
Zoetis
ZTS
Mkt Cap51.98B
Zoetis Inc. is a global animal health company that produces medicines and vaccinations for pets and livestock, overlapping with Neogen's market.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories offers a range of diagnostics products, including rapid diagnostics which compete with Neogen's food safety diagnostics.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific Inc. provides analytical instruments, reagents and consumables, and software services, competing in the life sciences sector with Neogen.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories, Inc. offers products for the life science research and clinical diagnostics markets, competing with Neogen's diagnostics solutions.
Qiagen NV
QGEN
Mkt Cap8.46B
Qiagen N.V. provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in similar markets as Neogen.
Waters
WAT
Mkt Cap29.85B
Waters Corporation produces analytical standards and reagents, instruments, and software, competing with Neogen in the analytical services and products sector.
Repligen
RGEN
Mkt Cap6.63B
Repligen Corporation provides bioprocessing technologies and solutions, which can be seen as complementary and competitive to Neogen's offerings in certain biotech applications.
Bruker
BRKR
Mkt Cap5.6B
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions, competing with Neogen in the provision of advanced tools for chemical analysis.

About

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Show more...
CEO
Ms. Amy M. Rocklin Ph.D.
Employees
2917
Country
US
ISIN
US6404911066

Listings

0 Comments

Share your thoughts

FAQ

What is Neogen stock price today?
The current price of NEOG is $9.49 USD — it has increased by +0.85% in the past 24 hours. Watch Neogen stock price performance more closely on the chart.
What is Neogen stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neogen stocks are traded under the ticker NEOG.
Is Neogen stock price growing?
NEOG stock has risen by +6.79% compared to the previous week, the month change is a -1.91% fall, over the last year Neogen has showed a +21.99% increase.
What is Neogen market cap?
Today Neogen has the market capitalization of 2.06B
When is the next Neogen earnings date?
Neogen is going to release the next earnings report on April 09, 2026.
What were Neogen earnings last quarter?
NEOG earnings for the last quarter are 0.1 USD per share, whereas the estimation was 0.06 USD resulting in a +58.1% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Neogen revenue for the last year?
Neogen revenue for the last year amounts to 1.79B USD.
What is Neogen net income for the last year?
NEOG net income for the last year is -2.18B USD.
How many employees does Neogen have?
As of April 06, 2026, the company has 2,917 employees.
In which sector is Neogen located?
Neogen operates in the Health Care sector.
When did Neogen complete a stock split?
The last stock split for Neogen was on June 07, 2021 with a ratio of 2:1.
Where is Neogen headquartered?
Neogen is headquartered in Lansing, US.